`Medtronic, Inc., Medtronic Vascular, Inc.,
`& Medtronic Corevalve, LLC
`v. Troy R. Norred, M.D.
`Case IPR2014-00395
`
`
`
`ill; "“
`
`‘\
`
`.“
`
`x
`
`II.
`
`Aortic Valve Dynamics and Physics
`
`The aortic valve is better understood in a dynamic state given it is not a
`static structure. To fully understand this structure it is integral to understand the
`opening and closing of the valve, the motion of the various parts, the design of the
`valve in vitro and the hydrodynamics of the valve. The valve’s ultimate function
`is to allow fluid transfer from the ventricle to the systemic circulation.
`In order to
`do this efficiently it minimizes shear stress, resistance to flow and tensile forces.
`The opening and closing of the aortic valve depends upon differential pressures,
`flow velocity characteristics andgas mentioned earlierythe unique anatomic relationship ,W,,N»‘1~*
`between the valves and the Qinuses of (galsalva. One of the most comprehensive study?
`encompassed a model developed by Bellhousejet al.
`In this model,
`the flow of fluid
`through the aortic valve was studied by injecting dye within the flow of fluid.
`Some of
`the pertinent observations found within this model were as follows: l) The valve opens
`rapidly, and as the leaflets move into the sinuses, vortices form between the leaflet and
`the sinus walls, 2) The flow enters the sinus at the sinus ridge, curls back along the sinus
`wall and leaflet and then back into the main stream; 3) During the end of systole the
`‘T’
`vorticeal motion created during contraction forces the valves back toward a closed
`position. These observations are important to show that absolute pressure differences
`created between the aorta and ventricl are not the source of initial closure of the aortic
`valves.
`In fact,
`it would be detrimlnal to valve stress if these forces dictated closure of
`the aortic valve.
`For example,
`if two objects are a greater distance apart and a set
`amount of force is applied to each, the greater distance would produce greater velocity
`and the momentum at impact would be greater. Therefore, if the leaflets are closed or
`near closure as contraction is coming to an end then the force used for coaptation would
`be less. Less force per cycle equates to greater longevity of the valve.
`In conclusion,
`the cusps and the relationship of closure for prosthetic valves must incorporate passive
`closure during systole which would logically lengthen the lifespan of any such device.
`To expand these concepts, we must explore the theory of laminar flow as it relates
`to aortic valve function.
`(laminar flow is predicted by Reynold’s number,which
`incorporates the laws as described by Pouiselle and Bernoulli.
`In general, the lower the
`Reynold’s number the more likely that flow will be laminar. The equation that describes
`the Reynold’s number in the aorta is as follows:
`
`KAN)
`Pi
`llfiflgig
`’(l'\Tuv.
`
`Ua/v = Reynolds number
`That is, U which equals the velocity of blood and (a) which represents the radius of the
`aortic valve is inversely related to the viscocity of blood%’)As the velocity increases or the
`viscocity decreases, the tendency torwards turbulent flow also increases. Moreover, the
`behavior of the system is also predicted by the rate of acceleration or deceleration which
`is described by the Strouhal number.
`In explanation,
`in a system where viscocity,
`velocity and radius vary slightly,
`the rate of acceleration or deceleration predicts laminar
`versus nofiaminar flow. When looked at in perspective,
`it is easy to see the relevance.
`Only a small pressure difference is required to open the native aortic valve. Maintaining a
`small pressure difference minimizes acceleration to flow. Thus,
`laminar flow is more
`likely. The deceleration phase is naturally a gradual process, however, as stated above it
`is the relationship between the sinuses and the cusps which allows this deceleration to
`
`NORRED EXHIBIT 2246 - Page 2
`NORRED EXHIBIT 2246 - Page 2
`
`
`
`occur without an abiupt pressure drop. When laminar flow is produced, the resistance to
`flow, wall stress, shear stress and circumferential stress is reduced. This reduction
`decreases cardiac work and increases the longevity of the valvular apparatus. Ultimately
`a design to replace a diseased aortic valve must incorporate many if not all of these
`relationships.
`
`Hf
`
`
`
`III.
`
`Adult Aortic Stenosis
`
`Aortic stenosis is a condition where there is a restriction to the ejection of
`blood from the left (‘,2 ventricle to the systemic circulation at the aortic valve level.
`If the aortic valve cusps do not open, or there is failure of the valvular apparatus,
`xkhun a pressure gradient develops.
`In order to overcome this pressure difference,
`the left ventricle begins to hypertrophy. Over a period of time this produces
`pressure overload on the left ventricle. Clinically, this produces dramatic
`symptoms, and in the most severe form it is fatal unless treated.
`The incidence of aortic stenosis varies considerably.
`In epidemiologic studies the
`incidence is between 2 to 4% of the general population.
`In the early 2011‘ century the
`most common etiology of aortic stenosis was rheumatic fever. This streptococcal
`infection produces inflammatory changes in the aortic valve.
`Interestingly, these
`changes affect the coaptation surface to a greater degree than the other structures of the
`aortic valve. Affecting the coaptation pointsaresults in fusion of cusps. This fiJ.SlOI‘l
`results in a restriction to the opening of the cusps. A pressure difference develops as well
`as non—laminar flow. Once this cycle develops, than the valve has increased deterioration
`and calcification. Unfortunately, post infectious aortic stenosis can result in rapid
`progression to severe aortic stenosis. Of the total cases of aortic stenosis in the l940’s,
`reportedly 52% were the result of rheumatic fever. Currently, less than 9% of the cases
`of aortic stenosis are postinflammatory.
`
`NORRED EXHIBIT 2246 - Page 3
`NORRED EXHIBIT 2246 - Page 3
`
`
`
`B
`
`( B )
`
`S
`
`L
`
`(A )
`
`L
`
`R
`
`N
`
` ..-W’
`
`V”
`
`M‘
`
`W
`
`
`
`’
`
`i
`\
`\
`\\
`
`t
`t
`“
`“”
`Aw/"
`The second most common cause of aortic stenosis is a bicuspid aortic valve. This
`has remained relatively constant throughout the decades.
`It accounts for 33 to 40% of the
`/ total cases of aortic stenosis. This condition affects most parameters of aortic function.
`lnherently, it loses the anatomic relationship between the sinuses and the valve cusp.
`Further, the opening and closing characteristics ofthe valve are altered,,which in turn
`alters the acceleration and deceleration to flow. As a result, non—laminar flow
`characteristics are developed. Because of the altered anatomy, a bicuspid aortic valve
`cannot easily reverse curvature. Due to this limitation, the bicuspid aortic valve has
`increased stress at the base.
`It is at this point where morphologic changes first appear.
`\, However,
`this valve is usually survived into adulthood.
`Currently, the most common cause of aortic stenosis is degenerative aortic
`stenosis. By the 7”‘ decade, the normal aortic valve can undergo degenerative changes.
`‘ ‘wt
`I
`_ Mk:
`The characteristics which define these changes are increased calcium deposition along
`the Qfibody of the cusps. «cPredominmfily~fl&ecalcificatien:i% located at the bases of the Ti;[Z.:§,.w«~;~=w~—l"
`cusp and on the aortic side. When enough calcium is deposited as to restrict flow,
`there will be a variable amount of fusion along the coaptation surface. The incidence of
`aortic stenosis reaches as high as 12% in octogenarians. This population accounts for
`51% of the current cases of aortic stenosis. The factors which promote aortic stenosis in
`
`I/zwr”
`__
`.;,«‘-
`
`{S
`
`NORRED EXHIBIT 2246 - Page 4
`NORRED EXHIBIT 2246 - Page 4
`
`
`
`
`
`a nomal valve are the same as those which affect atherosclerosis. (nejm 1996). Thus,
`degenerative aortic stenosis has become the most prevalent etiology.
`Clinically, symptomatic aoitic stenosis hasfi/oM‘t\oinl§f5disabling symptoms, but also
`a high mortality. Currently aortic stenosis is graded upon the calculated aortic valve area
`(figure7). As represented in the table,_severe aortic stenosis occurs when the valve area
`is less than l.Ocm2(AVA index of <O.6cm2/m2). The most frequent symptom is angina
`pectoris occurring in up to 70%. This is followed by syncope or presyncope. Once aortic
`stenosis becomes symptomatic, the 2 year mortality can be as high as 50% (Braunwal
`1973). The 10 year survival is a dismal 10%.
`In conclusion, aortic stenosis is a
`condition that can produce severe lifeelimiting symptoms and ultimately is fatal.
`
`IV.
`
`X\ortic regurgitation
`
`
`
`30
`
`30
`
`20
`
`Aortic liliitlagurgitation is a condition where there is backflow of blood from
`the aorta to the left ventricle. This regurgitation results in a decreased effective 7.,
`cardiac output.
`In turn, longstanding aortic regurgitation results in an increased
`amount of volume work on the left ventricle. In time, the left ventricle begins to
`dilate. Contrary to aortic stenosis, this condition can be well tolerated for many
`years. However, once the left ventricle begins to dilate and lose its contractility, it
`becomes rapidly symptomatic. The most common symptoms result from heart 7
`failure. Etiologically, aortic regurgitation and stenosis are very similar.
`
`NORRED EXHIBIT 2246 - Page 5
`NORRED EXHIBIT 2246 - Page 5
`
`
`
`
`
`The most common etiology of aortic regurgitation has been rheumatic
`fever. However, just as in stenosisgthis incidence has decreased as the incidence
`of rheumatic fever has decreased. Logically whenever there is stenosis there can
`be increase‘i3ircumferential stress placed upon the proximal aoitic root.
`It is this
`stress which promotes root dilatation in certain patients.
`l.\/Ioreover, a dilatation
`of the aortic root can in essence separate the cusps of the aortic valve and create
`regurgitation. Thus, senile aortic stenosis, bicuspid aortic valves and distinctly?’
`rheumatic aortic valves have a propensity to leak.
`'
`However, there are unique entities which promote aoitic regurgitation.
`For example, Marfan’s syndrome is a disease in which there is defective collagen
`deposition. This manifests as dilatation of the aortic root at a very young age,
`and tragically can result in the dissection of the aorta. More commonly, the
`aorta can become dilated in response to systemic hypertension.
`In a certain
`portion of patients, aoitic dilatation with concominent aoitic regurgitation is the
`only manifestation of their hypertension. Thus, there are distinct differences
`
`NORRED EXHIBIT 2246 - Page 6
`NORRED EXHIBIT 2246 - Page 6
`
`
`
`which can cause aortic regurgitation in the presence of a structurally normal aortic
`valve.
`
`Severe aortic regurgitation has a poor prognosis. From the work by
`Goldsclilager-let al it was found that the survival of aortic regurgitation is about
`50% at 8years (Am. J. Med.(54): 1973). With maximum medical therapy it still
`has a poor prognosis. Even among asymptomatic patients,
`there is a decrease in
`the max V02 as measured with a standard cardiopulmonary exercise test.
`Moreover, among those patients who undergo surgical replacement for aortic W L
`regurgitation, they report an increase level of functioning that they didn’t realize Tl
`they had lost.
`In fact, although more well tolerate, aortic valve regurgitation is a l
`serious disease which is limiting to a patient’s lifestyle as well as life.
`V. Surgical Therapy
`
`(w
`
`For patients suffering from aortic regurgitation or aortic stenosis, the best
`therapy to date is surgical. There is no questioning the benefit of surgical vs medical
`management for these conditions. The 5 year survival for symptomatic aortic stenosis is
`20% vs 80% with a standard valve replacement. The natural histoiy of the valve has
`been well characterized by the work of Braunwald et al in l 973. Unfortunately, aortic
`valve replacement carries certain surgical morbidity and mortality. :”‘~’¥ *3?
`Aortic valve replacement may be among the most invasive surgeries. Logically,
`the surgery requires access to the native valve which necessitates a sternotomy. Also, the
`heart must be stopped and placed on a bypass pump. Further, the ascending aorta is
`cross—clamped at a position proximal to the great vessels. The native valve is then
`excised, and depending upon the condition of the aortic root, it may be excised also.
`Then the mechanical or biomechanical valve is sutured into place. Although this is a
`life—saving procedure for those patients suffering from these disorders, the surgery is not
`without significant risk of mortality and morbidity.
`,_,/~
`The risks of the surgeiy can be classified as immediate and long term risks. The
`immediate risks of the surgery involve the mechanics of the valve replacement procedure.
`In accessing the heait, the sternum is split in two by a reciprocating saw. Given that this
`is a central point of attachment for the chest cavity, it must withstand considerable force.
`The sternum currently is wired back into place with a series((_),_rA/‘interrupted suture wire
`from the cranial end to the dorsal end. The difficulty is in wound dehiscence and
`infection. The patients who are at risk include the diabetics, the immunosuppressed and
`the elderly. Wound dehiscence or infection can be mild and readily amendable to simple
`wound care techniques. Or, these can be so severe as to lead to death or significant
`morbidity. The incidence is reported to be as low as l in 200 in low risk groups, and as
`high as 10 in 100 in high risk groups.
`Among the immediate risk there are significant decreases in cerebral fimction.
`The bypass pump allows the surgeon to operate in a controlled fashion to achieve good
`results.
`It is being more and more realized that this in and of itself promotes dysfunction.
`There is an immediate risk of major stroke which is reported to be I to 3%. However,
`among those patients without recognizable strokes, there are still reported neurological
`deficits and deficits in cognitive function. When this cognitive dysfunction is measure in
`terms of IQ points it can be dramatic.
`In one series, up to 60% of patient undergoing
`bypass surgery had an immediate drop in their IQ scores by 20 points. This can be
`
`V,
`5
`
`b
`
`NORRED EXHIBIT 2246 - Page 7
`NORRED EXHIBIT 2246 - Page 7
`
`
`
`dramatically recognized by family and Friends who are likely to report a distinct drop in
`mental alertness. Thus even in a techniquely successfiil surgery there can be a substantial
`drop in cognitive fimction.
`
`The long term rififinclude infectious endocarditis, thromboembolism and valve
`
`J
`
`dysfunction.
`
`Goals
`
`The objective of this study is to demonstrate the feasibility a percutaneously
`placed aortic valve.
`
`ll.
`
`Hypotheses:
`
`1.
`
`Lou!
`
`We speculate that a crosslinked nitinol expandable stent can be annealed
`to a biological valve (see appendix).
`We speculate that the flow characteristics produced by this uniquely
`designed device will perform in a similar fashion to that—o£other~l-luv“
`bioprosthetic valves.
`We speculate that the strain relationships will be proportionate to the
`native valve structure
`
`ltbt’
`/
`
`10.
`
`ll.
`
`.3
`~ -
`
`We speculate that the flexible base will allow more even dispersion of
`flexion strain.
`We speculate that the interface of the stent aorta will be sufiicient to
`maintain the valve in the proper position for fiinction in-vivo.
`We speculate that the stent/valve can be inserted percutaneously.
`We speculate that the ascending aorta can accomidate a stented valve
`structure without rupture or significant dissection.
`We speculate that the ascending aorta and coronary arteries can be
`visualized witiifitisting techniques.
`We speculate that with detailed visualization the stent/valve will be placed."
`as to avoid obstructing the native valve Function.
`‘“"'
`We speculate that the stent/valve combination will not significantly
`obstruct coronary How.
`We speculate that a biotome can be directed across the interatrial septum
`into the left ventricle.
`We speculate that once inserted into the left ventricle that the native valve L
`can be excised in a controlled manner.
`¢2_ muse.) ’I‘l;«t_,
`')~i c.._.t nature .3 t-M-" 3
`. We speculate that an animal would survive the placement of a
`percutaneous valve.
`We speculate that the stented aortic valve in vivo will have a gradient of
`less than l0mmhg.
`
`12.
`
`14.
`
`Ill.
`
`Equipment and supplies
`
`NORRED EXHIBIT 2246 - Page 8
`NORRED EXHIBIT 2246 - Page 8
`
`
`
`NORRED EXHIBIT 2246 - Page 9
`NORRED EXHIBIT 2246 - Page 9
`
`
`
`Lab associated equipment for the modification if needed of the existing
`i_\'
`'-
`.l
`valve. ."':.*'>
`'
`1-'1?“
`-
`.
`Nitinol wire
`
`Nitinol soldering device
`\-.
`Template equipment =:' v ..—-
`aqueous solutions for the flow system
`_-
`‘F__
`I] ,.
`"Preservation material (ll .
`Dissection tools
`
`\i\
`
`'.'_
`
`i-I
`
`fill‘
`
`\|
`
`"._|
`
`\_i
`
`.‘ i..( \,.___I
`
`e
`
`'
`
`Pig Hearts
`5-5» =‘
`Operating Room-,
`.f\Ju ..
`Valve Flow Model with software
`
`.
`
`"ii
`
`u~e..'.i
`
`. Statistical Software
`.Intracardiac echocardiography (Probes and Base)
`Catheterfir
`'|‘.xi‘lI..'3=:,-.
`‘
`(l'|Iu\»'-J
`4'. _
`14. Biotomes and microengineering tools
`Associates
`
`IV.
`
`_
`
`__
`ll ‘-.‘~
`
`"l ""
`
`‘
`
`V
`' 4 r‘
`
`i
`
`l
`
`" l
`
`.
`
`‘
`
`.
`
`.
`
`>‘
`
`5
`
`I
`
`I
`
`Flow Modeling
`i. Troy Norred MD
`ii. Steven Lombardo PhD
`
`iii. Frank Fu PhD
`
`Valve Development
`i. Troy Norred lv "-13
`ii. Fu Fung Hsieh ;"'l\l _.
`iii. Harold Huff l'_’_m*"'-.
`In Vitro Modeling
`i. Troy Norred MD
`ii. Steve Lombardo PhD
`
`iii. Fu Fung Hsieh PhD
`Procedure
`
`i. Troy Norred MD
`ii. Timothy Catchings MD
`iii. Darla Hess MD
`
`iv. Wayne McDanie1s PhD
`v. Michael Sturek PhD
`
`Editing and Data analysis
`i. Troy Norred MD
`ii. Greg Flaker MD
`iii. Fu Fung Hsieh PhD
`iv. Steven Lombardo Phd
`
`v. Timothy Catchings MD
`vi. Darla Hess MD
`vii. Frank Fu PhD
`
`viii. Wayne McDaniels PhD
`ix Michael Sturek{PhD
`Data Acquisition Q‘/is 1
`|
`.1
`1': 1 l
`.__1’
`_
`Hemodynamics
`
`1'
`
`1,
`(L
`
`‘.
`
`.
`1'1
`E3
`
`-.-'\\\J
`‘.|
`_“
`
`\‘.‘__:._ )\\] -xix .
`I‘
`\-.
`..
`5,.
`J
`_
`i
`\
`-
`1
`L‘.
`t'\
`
`l‘.*.\‘_ H -.,«.
`
`-.;_
`
`S
`
`U
`
`\
`
`.
`
`I
`
`.
`
`1"‘
`
`-ii
`
`i
`
`E
`
`\
`
`'
`
`-
`
`\
`
`i
`
`i
`"
`-. \
`.
`_,i ..
`. \\ N:
`'
`_l
`\.‘
`ll»-L }- "
`
`NORRED EXHIBIT 2246 - Page 10
`NORRED EXHIBIT 2246 - Page 10
`
`
`
`i.
`
`ii.
`
`Pressure gradients
`Cardiac Output
`Peripheral resistance
`2. Dissection of the specimens
`i.
`Histologic Data
`ii.
`Morphologic data
`ization Data
`
`iii.
`
`3. Visual
`
`VI.
`
`In—Vitro Modeling system
`4.
`5. Histological sections
`Budget
`'1 . Flow Model System
`i.
`Laser Doppler Anometer
`Vivitec Flow Model
`Software analysis System
`Post~Doc Salary for 6 weeks
`Secretarial Time
`
`ii.
`iii.
`
`iv.
`v.
`
`($1500.00)
`($13,500)
`($650.00)
`($3 750.00)
`($l 2.00/hr X25
`
`vi.
`
`2. Valve
`
`hr/wk)
`Sodium lodide, glycerol, l%water by volume($75.00)
`Modification
`
`i.
`
`ii.
`
`Pig Hearts
`l. Slaughter House Material
`2. Technician Processing Time
`Preservation Material
`
`1. Liquid Nitrogen
`2. Formalin
`
`clean up time
`3.
`4. Freezer Space Rental
`5. Lab Space Rental
`Nitinol Wiring
`1. Soldering Kit
`2. Nitinol wiring
`3. Engineering Consultant Fee
`Technician and Physical Plant time
`Secretarial Expense
`l.
`10 hours/week
`
`iii.
`
`iv.
`
`vi.
`
`($10.00/heart)
`($150.00)
`($17.00/hr)
`
`($25.00/canister)
`($5.00/6oz)
`(17.00/hr)
`($010.00/day
`(13.00/hr)
`
`($1950.)
`($950.00/ft)
`($2500.00)
`($25.00/hr)
`
`3. Experi
`i.
`
`ii.
`
`iii.
`
`iv.
`v.
`
`vi.
`
`vii.
`
`viii.
`4. Total c
`
`ment with Pigs
`($75.00/pig)
`Pigs
`($110.00/day
`Fluoroscopic Time
`($17.00/hr)
`Technician time
`($500.00)
`Lab expense
`Catheters (variable if donated, but approx. $200.00)
`Data Software (included in Flouroscopic room)
`Statistician Expense
`($250.00)
`Segretarial Time (20hrs)
`ostf of fofié week project
`
`$36,610.00
`
`NORRED EXHIBIT 2246 - Page 11
`NORRED EXHIBIT 2246 - Page 11
`
`
`
`
`
`l
`
`l5
`
`
`
`VII.
`
`Protocol
`
`1. Flow Modeling
`The initial experiments will be performed to assess the valvular function in a
`flow model. As listed in equipment and supplies, the systems used include a
`simulated flow model and devices used to measure the pressure and resistance.
`(see adjacent picture). The models are static and therefore limit the assessment.
`However, important stress and strain relationships can be obtained. The valve
`will be initially placed by hand in the model system. The basic measurements
`will be derived, and fi*om these measurements we will publish our first data on the
`experimental valve. The timeline for these experiments are thought to be 4 to 6
`weeks. The initial bulk of our time will be in the preparation for these
`experiments. During this time several mock runs will be used to modify the
`devices as necessary to obtain the most accurate hemodynamic information.
`Once we have accurate information concerning laminar flow characteristics,
`Reyno1d’s number and strain relationships, we will procede to practice for in-
`vivo experiments.
`The flow system has been developed to have set points of measurements
`embedded at certains distances from the valve,
`In a pulsed laser system, the lasers
`are set at perpendicular angles to measure differential velocities. Further, these
`velocities can measure shear stresses along the systolic flow and regurgitant flow.
`In the flow models, there can be taken high speed photography to demonstrated
`the function of early closure in relationship with sinuses.(Annals of Biomedical
`Engineering. Vol. 26). Thus, the flow model measurements coupled with
`functional data will be reported.
`The final phase of these experiments will help prepare for a more
`successful attempt at in-vivo placement of the experimental valve. With current
`software available from Meinry Corporation, we will have the data necessary to
`begin modification of the valve system before our in-vivo attempts. This software
`can help deduce strain relationships in a computer model. Differing values can
`be used to assess the effects that variations in different geometric configurations
`alter the function. Thus, with detailed in~vitro experiments we will save valuable
`time and resources in pre—experimental
`trouble shooting.
`2. Valve modification
`
`The valve/stent combination has reached a point in design and
`development where modification must be backed by experimental direction. The
`initial design has several areas that may need modification. The most obvious is
`the stent arrangement. For maximum compression, it has been proposed that an
`interlaced series of nitinol wire would be favorable. This may hold to be true,
`however, reinforcement at the base may be necessary for more stability. Further,
`carefiil consideration of the sinuses may necessitate a more direct modeling
`system.
`.lt is possible that for each individual aortic root the normal variance may
`preclude a one size fits all approach. For example, the placement of the coronary
`ostium varies significantly among individuals.
`It seems logical that a system
`which avoids directly obstructing the coronaries would be preferable. Differing
`designs can be employed to exactly set the relationship of an opening in the
`stented structure. The angle between the coronaries, the depth of the sinuses, the
`
`NORRED EXHIBIT 2246 - Page 12
`NORRED EXHIBIT 2246 - Page 12
`
`
`
`size of the cusps directly opposite the ostia and the degree in which the stented
`segments contour the ostia may be needed for the most effective percutaneously
`replaced valve.
`With the placement of the valve, it is crucial to allow enough distance
`between the native valve and the coronaries.
`It has been shown that differing
`techniques of harvesting biological valves can have a dramatic impact on the
`function. When a valve is harvested and placed in formalin, it undergoes an
`amount of swelling from cellular death and necrosis. This can increase the
`thickness of the valve. Increasing the thickness ofthe valve can be detrimental to
`the placement by inhibiting the flow of blood into the coronary ostia. Moreover,
`with more cellular death the longevity and function of the valve may be
`negatively implacted. Our initial valve development will necessitate differing
`techniques of preservation. We will try simple formalin preserved valves as well
`as cryopreserved valves. Differing buffering solutions may also be evaluated if
`found necessary. Thus there are several considerations in the modification of this
`valvular model.
`
`I have made several prototypes and find considerable variability in the
`interface of the stent and valve. Whether this variability will be important in the
`overall function of the valve is unknown at this time. Our initial experience
`reveals the meticulous nature of the annealing process. If a single suture is
`disrupted the the entire valvular apparatus can tear. Diligent work and
`documentation to the most effective way to anneal the two components of the
`valve is necessary. Fortunately, much of this work has begun and many lessons
`have been learned, but more time and resources will need to be devoted to this
`line of modification. An estimate of one 40 hour week dedicated to this
`endeavor is realistic.
`
`A potential problem with a nonsurgically placed valve is perivalvular leak.
`If the edges of the valve begin to lift and form a low resistance channel, the valve
`may begin to develop torque upon itself which may ultimately lead to valvular
`dysfuntion and even failure.
`In addressing this hypothetical problem, it has been
`proposed to use a rim of pervalvular material to act as a counter valve which seals
`itself hydrostatically and prevents or limits peri—valvular leak. The in-vitro flow
`model with be invaluable in assessing this possibility. We will use the time at the
`end of the flow modeling to adjust for this possibility. Of the many possibilities
`that have been entertained, the two most direct methods of limiting this possibility
`are root mimicry and pericardial sleeves.
`In explanation, the root with the sinus
`morphology preserved will be attached to the proximal portion of the stented
`structure. Therefore, when the structure expands the the lateral force of blood
`will create a large surface from which the intima can adhere. This same concept
`may be applied to the pericardium.
`It may be more useful because it is more
`maliable and more easily sutured into the stent structure. It is readily apparent
`that a detailed evaluation of the valve functions in each area will be needed before
`
`advancing to in-vivo experiments.
`The final consideration of valve modification involves the deployment of
`the stented valve. Several issues are potentially limiting in the expansion of a
`collapsed valve. The most immediate concerns involve the ability of the
`
`NORRED EXHIBIT 2246 - Page 13
`NORRED EXHIBIT 2246 - Page 13
`
`
`
`stent/valve connections to hold while expanding. Our initial experience has been
`favorable, but upon close evaluation of the valves we have discerned micro tears
`in the suture. These micro tears are obviously concerning in the development of
`mechanical failure. Potential solutions to this problem involve differing suture
`techniques and bioglue to seal the valve before it is collapsed. Histological
`examination will be required when the in-vitro model is tested. After all these
`points have been addressed we will proceed to in-vivo modeling.
`3. Catheter design
`The catheters required to place the experimental valve will be kept veiy
`simple initially. We will use the largest catheters available in the initial in-vitro
`attempts. The catheters from outdated stock are unfortunately too small.
`However, contact with cordis has produced some promising leads as to the
`availability of larger catheters. Further, in the Dept. of Engineering, there are
`facilities available for the development of new catheters. If needed, Dr.
`Lombardo and Dr Fu have the ability to liaison this portion of the experiment.
`The in-vivo experiments will necessitate an entire system of native valve
`modification or extraction.
`1 have designed different catheters which promote the
`percutaneous removal of the aortic valve. However, it is premature to diveit
`much time to its development in the initial stages. As a matter of discussion, the
`most direct way of removing tissue is by biotome extraction. Upon this theme
`several different catheter types have been proposed, but
`the most usefiil will
`employ an anchoring device in to the thickened aortic valve.
`Initially, a catheter
`will be guided into the left ventricle via a transeptal approach. The catheter will
`be attached by a deployable screw into the native valve. This will allow the
`catheter to move with the valve movement. By moving with the valve
`translational variation with movement will be minimized. For example, if a man
`is on a ladder which is swaying alongside a telephone pole which is also swaying
`then making repairs would be difficult. Especially if the two movements were
`independent of each other. However,
`if the man were wrapped to the pole then
`the pole and the man are moving with the same motion. To the man, it would
`appear as if the pole were stationary. The same concept applies with extraction of
`a moving valve. With the device anchored, controlled sections of the native valve
`will be snipped out. It is unknown at this time whether complete removal of the
`aortic valve will be necessary. At a minimum, there will always be a rim of
`valve remaining on which the percutaneous valve will sit. With further
`understanding of the technique it has become apparent that simple aggressive
`debulking may accomplish the same task. Thus, both possibilities should be
`explored.
`The second set of catheters are a more ambitious project. These catheters
`involve the system of rotablation.
`In this design, a catheter with two lumens is
`used to guide a rotablator device onto the native valve. The tip of the catheter has
`a roof of material to serve as a template guide. This allows the rotablator device
`to come into contact with the native valve and chip away the native structure. A
`continuous high flow saline solution is directed into the return lumen of the
`catheter. This creates a venturi effect upon the tip of the valve. The particulate
`matter is directed into the return lumen and back into a waste reservoir. However,
`
`
`
`A
`
`1
`
`NORRED EXHIBIT 2246 - Page 14
`NORRED EXHIBIT 2246 - Page 14
`
`
`
`if any particles escape, the size of the particle should be exceedingly small. This
`would naturally limit the amount of injury from peripheral embolization.
`4.
`In Vivo Experiments
`The final stage of experiments will involve the placement of the stent
`valve into an animal. This experiment will start with the detailing of the aortic
`valve anatomy. A intracardiac echoprobe (ICE) will be advanced into the right
`atrium where a detailed view of the aorta is possible. The basic measurements of
`the root structures will include the valvular morphology and the description of the
`coronary ostia. Dr Darla Hess will be a collaborator in this area. From this
`description, the radius of the stent at final deployment will be known. This
`information will be used to individualize the stent to the experimental animals
`aorta. Also, the ICE will be used to measure the stent/aorta interface and the
`details of the experimental valve post deployment.
`The initial design will use sacrificed animals. The animals will be put
`under anesthesia and peructaneously a catheter will be advance into the ascending
`aorta through a sheath system, The valve is self expanding and will be deployed
`by backing the catheter off of the stented portion of the valve. With the valve
`properly seated, a detailed recording of its fimction will be made by the
`intracardiac echoprobe. Also, basic hemodynamic data will be gathered. A
`transeptal catheter will simultaneously record left ventricular pressure with
`ascending aorta pressure recorded from the stent catheter. The animal will be
`maintained through the day and sacrificed after approximately 8 hours. The aorta
`and root structures will be analyzed histologically for evidence of intimal
`dissection and rupture.
`Given the limited amount of time, a living animal model will not be
`attempted in the initial experiments. However, given that the basic
`hemodynamics can be acquired, this will be adequate to document the feasibility
`of the technique. The later experiments will include percutaneous removal and
`replacement of the native valve structure.
`
`VI Theory of Percutaneous Replacement
`1. Physics and equations
`2. Mathematics
`
`3. Dispersion of Force/area
`4. Maintenance of normal anatomic relationships
`Flexion
`
`Q‘~'?3"°.‘°.-'3-.0.°‘§-‘°
`
`Reversal of curvature
`
`Barrow effect of the proximal aorta
`Dispersion ofForces along the sinuses
`Increasing flow characteristics of the coronaries
`Edy currents in the sinuses promotes early closure and reduces wear
`Favorable strain characteristics
`
`NORRED EXHIBIT 2246 - Page 15
`NORRED EXHIBIT 2246 - Page 15
`
`
`
`h. Laminar flow preservation
`
`The understanding of the basic biological and physical properties of the aortic
`valve prompted my development of a novel approach to its replacement. As described
`above, with an expanded stent into the ascending aorta th